Item 5.07. Submission of Matters to a Vote of Security Holders.

On December 3, 2021, Foresight Acquisition Corp. (the "Company") re-convened its special meeting of stockholders (the "Special Meeting") in connection with the proposed business combinations (the "Business Combinations") contemplated by the Agreement and Plan of Merger, dated as of May 25, 2021 (as amended or restated from time to time, the "Merger Agreement"), by and among the Company, P3 Health Group Holdings, LLC ("P3") and FAC Merger Sub LLC ("P3 LLC") and the Transaction and Combination Agreement, dated as of May 25, 2021 (as amended or restated from time to time, the "Transaction and Combination Agreement"), by and among the Company and the blocker entities, blocker sellers and other parties party thereto, as described in the definitive proxy statement filed by the Company with the SEC on October 28, 2021 (the "Proxy Statement"). Present at the reconvened Special Meeting were holders of 28,496,046 shares of the Company's Class A common stock, par value $0.0001 per share ("Class A Common Stock"), in person or by proxy, representing 70.598% of the voting power of the Class A Common Stock as of October 8, 2021, the record date for the Special Meeting (the "Record Date"), and constituting a quorum for the transaction of business. As of the Record Date, there were 40,363,750 shares of Class A Common Stock issued and outstanding.

At the Special Meeting, the Company's stockholders approved the Business Combinations Proposal, the Charter Amendment Proposal, the Bylaw Amendment Proposal, the Governance Proposals, the Nasdaq Proposal, and the 2021 Plan Proposal, in each case as defined and described in greater detail in the Proxy Statement. The Adjournment Proposal, as defined and described in greater detail in the Proxy Statement, was not presented to the Company's stockholders as the Business Combinations Proposal, the Charter Amendment Proposal, the Bylaw Amendment Proposal, the Governance Proposals, the Nasdaq Proposal and the 2021 Plan Proposal each received a sufficient number of votes for approval.

Set forth below are the final voting results for the Business Combinations Proposal, the Charter Amendment Proposal, the Bylaw Amendment Proposal, the Governance Proposals, the Nasdaq Proposal and the 2021 Plan Proposal:

The Business Combinations Proposal

The proposal to approve and adopt the Merger Agreement and the Transaction and Combination Agreement and the transactions contemplated thereby, was approved. The voting results of the shares of the Class A Common Stock were as follows:





   For        Against    Abstentions
26,164,913   2,276,533     54,600

The Charter Amendment Proposal

The proposal to approve and adopt the proposed second amended and restated certificate of incorporation of the Company attached as Annex C to the Proxy Statement (the "Proposed Charter"), was approved. The voting results of the shares of the Class A Common Stock were as follows:





   For        Against    Abstentions
26,155,908   2,285,638     54,500

The Bylaw Amendment Proposal

The proposal to approve amendments to the Company's bylaws, in the form of the amended and restated bylaws attached as Annex D to the Proxy Statement (the "Proposed Bylaws") was approved. The voting results of the shares of the Class A Common Stock were as follows:





   For        Against    Abstentions
26,155,918   2,285,628     54,500

--------------------------------------------------------------------------------

Governance Proposals

The following eight (8) separate governance proposals (the "Governance Proposals") relating to the following material differences between the Company's current amended and restated certificate of incorporation and the Proposed Charter and the Company's current bylaws and the Proposed Bylaws, were approved on a non-binding advisory basis. The voting results of the shares of Class A Common Stock for each of the Governance Proposals were as follows:

Proposed Charter





    (a)  Advisory Governance Proposal 4A-to increase the number of authorized
         shares of Class A Common Stock from 200,000,000 to 800,000,000 and
         increase the number of authorized shares of preferred stock from
         1,000,000 to 10,000,000:




   For        Against    Abstentions
24,058,128   4,383,918     54,000




    (b)  Advisory Governance Proposal 4B-to create a new class of capital stock,
         Class V Common Stock, which will carry certain voting rights but no
         economic rights, and set the number of authorized shares of Class V
         Common Stock to 205,000,000:




   For        Against    Abstentions
24,655,316   3,785,730     55,000




    (c)  Advisory Governance Proposal 4C-to provide that the post-combination
         company renounces all interest and expectancy that the post-combination
         company would be entitled to have in, and all rights to be offered an
         opportunity to participate in, any business opportunity that from time to
         time may be presented to Foresight Sponsor Group, LLC and Chicago Pacific
         Founders or their affiliates (other than the post-combination company and
         its subsidiaries), and any of their respective principals, members,
         directors, partners, stockholders, officers, employees or other
         representatives (other than any such person who is also an officer or
         employee of the post-combination company or its subsidiaries), or any
         director or stockholder who is not employed by the post-combination
         company or its subsidiaries:




   For        Against    Abstentions
24,056,908   4,385,138     54,000




    (d)  Advisory Governance Proposal 4D-to provide for certain additional
         changes, including, among other things, (i) changing the corporate name
         from "Foresight Acquisition Corp." to "P3 Health Partners Inc.", (ii)
         making the post-combination company's corporate existence perpetual, and
         (iii) removing certain provisions related to the Company's status as a
         blank check company that will no longer be applicable upon consummation
         of the Business Combinations, all of which the Company's board of
         directors believe is necessary to adequately address the needs of the
         post-combination company after the Business Combinations:




   For        Against    Abstentions
26,154,903   2,286,143     55,000




    (e)  Advisory Governance Proposal 4E-to modify the forum selection provision
         to designate the U.S. federal district courts as the exclusive forum for
         claims arising under the Securities Act of 1933, as amended (the
         "Securities Act") and provide that the forum selection provision will not
         apply to claims seeking to enforce any liability or duty created by the
         Securities Exchange Act of 1934, as amended (the "Exchange Act"):




   For        Against    Abstentions
25,544,388   2,896,658     55,000


--------------------------------------------------------------------------------

Proposed Bylaws





    (f)  Advisory Governance Proposal 4F-to update the advance notice requirements
         for stockholder proposals and nominations to require enhanced disclosure
         about both the proposing stockholder and the nominee, including director
         questionnaires, disclosures of voting commitments and compensation
         arrangements, representations that any nominee will comply with all
         post-combination company board policies and enhanced disclosure of
         derivative and synthetic ownership interests:




   For        Against    Abstentions
26,152,399   2,289,647     54,000




    (g)  Advisory Governance Proposal 4G-to provide that special meetings of
         stockholders may be called by the Chairman of the post-combination
         company board or a majority of the whole board:




   For        Against    Abstentions
24,061,438   4,380,308     54,300




    (h)  Advisory Governance Proposal 4H-to change the required vote for
         stockholder approval in order to alter, amend or repeal the bylaws from
         the affirmative vote of a majority of the voting power of all outstanding
         shares of capital stock of the post-combination company entitled to vote
         generally in the election of directors, voting together as a single
         class, to at least sixty-six and two-thirds percent (66 2/3%) of the
         voting power of all of the outstanding voting stock of the
         post-combination company entitled to vote:




   For        Against    Abstentions

24,650,018   3,792,028     54,000


Nasdaq Proposal

The proposal to approve, in connection with the Business Combinations, for purposes of complying with applicable listing rules of The Nasdaq Capital Market: (a) the issuance of (i) shares of Class A Common Stock to the blocker sellers in the transactions contemplated by the Transaction and Combination Agreement and (ii) shares of Class V Common Stock to the P3 equityholders who subscribe for shares of Class V Common Stock in the P3 equityholders subscription, with the number of such shares of Class A Common Stock and Class V Common Stock being up to 10,048,179 and 202,551,822, respectively; (b) the issuance, in a private placement to be consummated concurrently with the closing of the Business Combinations, of up to 20,870,307 shares of Class A Common Stock for a purchase price of $10.00 per share and an aggregate purchase price of approximately $208.7 million pursuant to the terms of subscription agreements entered into with institutional accredited investors; and (c) the issuance of a number of shares of Class A Common Stock equal to the number of shares of Class V Common Stock issued in connection with the Business Combinations and the Merger Agreement, up to 202,551,822 shares, which shares of Class A Common Stock will be issuable to the holders of such shares of Class V Common Stock in connection with the future exchange of their equity interests of P3 LLC and shares of Class V Common Stock in accordance with the amended and restated limited liability company agreement of P3 LLC to be entered into in connection with the closing of the Business Combinations, was approved. The voting results of the shares of the Class A Common Stock were as follows:





   For        Against    Abstentions
26,155,899   2,286,147     54,000

--------------------------------------------------------------------------------

2021 Plan Proposal

The proposal to approve the adoption of the P3 Health Partners Inc. 2021 Incentive Award Plan was approved. The voting results of the shares of the Class A Common Stock were as follows:





   For        Against    Abstentions
26,152,084   2,288,657     55,305

Holders of an aggregate of 27,887,684 shares of Class A Common Stock exercised their right to redeem their shares.

--------------------------------------------------------------------------------

© Edgar Online, source Glimpses